• MyliconGas 40mg 50 chewable tablets
1 1

Johnson & Johnson

MyliconGas 40mg 50 chewable tablets

MyliconGas 40mg 50 chewable tablets

€16,27
€17,49 €16,27
Sale Sold out
VAT included. Shipping calculated at checkout.
Logo Farmaci da banco

NET WEIGHT OF THE PRODUCT

50ct

EAN

038140012

MINSAN

038140012

View full details

In compliance with article 118 "authorization of advertising to the public" of the legislative decree of 24 April 2006, number 219

INDICATIONS

Symptomatic treatment of gastrointestinal meteorism and aerophagia in adults.

CONTRAINDICATIONS

Hypersensitivity to the active substance or to any of the components listed in paragraph 6.1.

WARNINGS AND PRECAUTIONS FOR USE

After a short period of treatment without appreciable results, consult your doctor. In case of persistence, worsening of symptoms, or if new symptoms appear or in case of prolonged constipation, stop treatment and consult your doctor. Do not use in case of suspected intestinal perforation or ileus. Important information about some excipients Mylicongas contains lactose. Patients suffering from rare hereditary problems of galactose intolerance, total lactase deficiency, e.g. galactosemia, or suffering from glucose/galactose malabsorption, should not take this medicine. Mylicongas contains less than 1 mmol (23 mg) of sodium per dose. It can therefore be considered essentially sodium-free.

INTERACTIONS

Taking SIMETICONE and mineral oil (paraffin) laxatives at the same time is not recommended, as the combination of these two products reduces their effectiveness.

SIDE EFFECTS

Side effects observed during treatment in clinical studies and integrated with those collected during post-marketing experience are listed in the table below according to System Organ Class (using MedDRA terminology) and according to the following frequency: Very common ≥ 1/10; Common ≥ 1/100 and < 1/10; Uncommon ≥ 1/1,000 and < 1/100; Rare ≥ 1/10,000 and < 1/1,000; Very rare < 1/10,000.

Gastrointestinal disorders

Very rare | Vomiting, diarrhea, abdominal pain, ileus, nausea

Pathologies of the skin and subcutaneous tissue

Very rare | Angioedema, Rash

Immune system disorders

rare | hypersensitivity reactions

Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at “https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse”.

OUR PRODUCTS FOR THIS SEASON

1 10
View all
1 4

Responsibility for content
This sheet contains information that is not intended to replace a diagnosis or medical advice, as only a doctor can write any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.

Please note
The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they could be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the published information.

Data source: Farmadati Italia
Website: www.farmadati.it

The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalists, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory.

The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.